Risk of bowel ischemia in patients with mesenteric neuroendocrine tumors after treatment with 177Lu-DOTATATE

Acute bowel ischemia may be a rare complication of PRRT in patients with mesenteric arterial or venous obstruction from mesenteric metastasis.

Authors

Institutions

Publication Details

Journal
Endocrine Oncology
Published
2025-01-01
DOI
https://doi.org/10.1530/eo-25-0033
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk of bowel ischemia in patients with mesenteric neuroendocrine tumors after treatment with 177Lu-DOTATATE

Eleonora Pellè, Brian Morse, Bhavana Konda, Taymeyah Al‐Toubah et al.
Endocrine Oncology
Neuroendocrine Tumor Research Advances
article

Risk of bowel ischemia in patients with mesenteric neuroendocrine tumors after treatment with 177Lu-DOTATATE

Eleonora Pellè, Brian Morse, Bhavana Konda, Taymeyah Al‐Toubah, Jonathan Strosberg, Vineeth Sukrithan, Ghassan El‐Haddad
article en

Abstract

Acute bowel ischemia may be a rare complication of PRRT in patients with mesenteric arterial or venous obstruction from mesenteric metastasis.

Endocrine OncologyVol. 5(1)
Moffitt Cancer Center (US), The Ohio State University (US)
Openalex Percentile: Top 79%
Neuroendocrine Tumor Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.